Gabapentin
Product Images NDC 67046-224

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 67046-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Chemical Structure (9c400666 A559 471f 9024 2f5b24455dee 01)

Chemical structure diagram of the active ingredient gabapentin, displaying its molecular framework including a cyclohexane ring and attached amine and carboxyl groups.*

FDA Label Image

Image Of Figure 1 (9c400666 A559 471f 9024 2f5b24455dee 02)

A line graph depicting mean pain scores over an 8-week period comparing placebo and Gabapentin, 3600 mg/day. The horizontal axis shows time in weeks with a 4-week dose titration period followed by a 4-week fixed dose period. The vertical axis measures mean pain score from 0 to 10. Gabapentin shows a decreasing trend in pain scores, whereas placebo remains relatively stable. Statistical significance (p < 0.01) is indicated at multiple points.*

FDA Label Image

Image Of Figure 2 (9c400666 A559 471f 9024 2f5b24455dee 03)

A line graph comparing mean pain scores over eight weeks between placebo and Gabapentin 3600 mg/day groups. The x-axis represents weeks including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows pain scores from 0 to 10. Gabapentin group shows a significant reduction in pain scores compared to placebo, marked with statistical significance (p < 0.01).*

FDA Label Image

Image Of Figure 3 (9c400666 A559 471f 9024 2f5b24455dee 04)

A bar graph showing the percentage of responders at endpoint from two studies comparing placebo (PBO) and Gabapentin (GBP) at different dosages (3600 mg, 1800 mg, 2400 mg). The graph indicates higher responder percentages for Gabapentin groups versus placebo with statistical significance noted (p<0.01 and p<0.001).*

FDA Label Image

Image Of Figure 4 (9c400666 A559 471f 9024 2f5b24455dee 05)

A scatter plot comparing percentage difference by daily dose (mg) for Gabapentin across three studies labeled a, b, and c. The x-axis represents daily dose (600, 900, 1200, and 1800 mg), and the y-axis shows difference percentages from 2% to 22%. Distinct markers indicate data points for each study at varying dose levels.*

FDA Label Image

300 mg Blister Of 30 (9c400666 A559 471f 9024 2f5b24455dee 06)

A medication reminder card for Gabapentin 300 mg capsules, labeled by Contract Pharmacy Services-PA. The card features numbered slots for up to 30 doses and includes storage instructions to keep at controlled room temperature. There are fields for filling pharmacy and medication information, including fill date, strength, expiration date, manufacturer, and lot number spaces.*

FDA Label Image

400 mg Blister Of 30 (9c400666 A559 471f 9024 2f5b24455dee 07)

This is a multi-dose pill organizer label for Gabapentin 400 mg capsules, quantity 30, packaged by Contract Pharmacy Services-PA. It features a 30-day calendar layout with numbered slots for daily medication tracking and includes spaces for filling information, such as medication strength, expiration date, and lot number. The label includes storage instructions and a caution that the package is not child resistant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.